RMD 1.05% $37.39 resmed inc

Sleep apnea detection, page-12

  1. 525 Posts.
    lightbulb Created with Sketch. 69
    Gongboy, I think the key points here are:

    (1)  sleep apnoea is a severely un-diagnosed condition
    (2) despite this Resmed have built a marvellous business with a stellar $22b market cap
    (3) Current sleep labortory diagnosis is expensive $1000 - $2000, and inconvenient - as you need to sleep the night at a designated lab., and even then the test can fail requiring a repeat
    (4) So far, Resapp can diagnose sleep apnoea with 80-82% sensitivity and specificity (I say so far because it is early days and i expect over time this will get better)
    (5) That is a very high accuracy and very cheap and convenient, and can be repeated many times
    (6) Seems clear to me this tech would be very useful to increase diagnosis for Resmed or any competitors to grow market share.
    (7) have a look at the pictures below (I know using the Rap device wont make you 30 years younger but you see what I mean)
    (8) Compare accuracy, convenience, cost and repeatability - Resmed should takeover or licence this tech before their competitors do.


    rap1.png V's rap2.png
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.39
Change
0.390(1.05%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.30 $37.39 $37.07 $9.449M 253.3K

Buyers (Bids)

No. Vol. Price($)
1 44 $37.32
 

Sellers (Offers)

Price($) Vol. No.
$37.39 2573 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.